Panel Discussion: From Vision to Reality: What Will Actually Get Adopted in Process Monitoring?

• Which process monitoring technologies will actually deliver measurable ROI in the next 3–5 years, and how do you prioritise investment to avoid over‑promising and under‑delivering?
• How can organizations confidently balance innovation with GMP risk, product sensitivity, cost, and operational complexity to ensure new technologies enable rather than disrupt manufacturing performance?
• In what ways can evolving regulatory guidance be leveraged to accelerate adoption and strengthen control strategies, rather than acting as a barrier?
• What approaches actually work when retrofitting new monitoring tools into legacy systems, and when does it make more sense to invest in greenfield solutions?

Speakers:

Joshua Kulakofsky

Associate Director, Formulation Development

Noven Pharmaceuticals

Ramila Peiris

Global Head of Data Management, Machine Learning, Artificial Intelligence Platform, Manufacturing Science & Technology

Sanofi